Fig. 3From: Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteriaAssociation between clinicopathological features, immunohistochemical factors and distant metastasis-free survival over the first 5 years in the Luminal B Her2-negative group of breast cancer patientsBack to article page